Discover a new way to find and share stories you'll loveā€¦ Learn about Reading Desk

Post Profile



Slumdog Clinical Trials contd.

Drug major GlaxoSmithKline (GSK) has unethically tested a breast cancer drug on poor patients in India for approval for new drugs in the Europe Union, said a study. According to an investigation by Mumbai-based Centre for Studies in Ethics and Rights, the firm tested lapatinib on patients flouting Indian Council of Medical Research's (ICMR) ethical guidelines.This trial required seriously ill patients who had not received treatment for their condition.
read more

share

GSK Seeks Approval Of Advanced Breast Cancer Drug For First-Line Treatment

Health : Medical News Today (6 years ago)

GlaxoSmithKline on Wednesday applied for approval to market its breast cancer drug Tykerb in U.S. and Europe as a first-line treatment for women with advanced, hormone-sensitive breast cancer, the AP/Google.com reports. Tykerb, know... Read Post

Study Examines FDA Influence on Design of Pivotal Drug Studies

Health : Newswise Medical News (10 hours ago)

An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred without any meeting,... Read Post

2 New Drugs Greater Than Sum of Parts Against Colorectal Cancer

Health : Newswise Medical News (15 hours ago)

Experimental anti-cancer drugs PF-04691502 and PD-0325901 excel in tests against colorectal cancer models and enter phase 1 clinical trial. Read Post


Copyright © 2011 Regator, LLC